WashingtonMost new drug-regulator peptide panelists also sell peptides.
The Food and Drug Administration committee decides which peptides compounding pharmacies may manufacture — a ruling that directly benefits the majority who prescribe them.
Biochemist Paul Knoepfler said the panel confirms Health Secretary Robert F. Kennedy Jr.’s intent to favor unproven peptides.
Sources: STAT